Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
J Virus Erad
.
2021 Mar;7(1):100032.
doi: 10.1016/j.jve.2021.100032.
Epub 2021 Feb 7.
Authors
Jillian Sy Lau
1
,
Thomas A Rasmussen
2
,
Sharon R Lewin
1
2
,
Adam Ehm
3
,
Cipriano Martinez
4
,
Craig Burnett
3
,
James H McMahon
1
5
Affiliations
1
The Alfred Hospital and Monash University, Victoria, Australia.
2
The Peter Doherty Institute for Infection and Immunity, And the University of Melbourne, Victoria, Australia.
3
Melbourne HIV Cure Consortium Community Advisory Board, Living Positive Victoria, Australia.
4
National Association of People Living with HIV Australia, New South Wales, Australia.
5
Monash Medical Centre, Victoria, Australia.
PMID:
33585037
PMCID:
PMC7868108
DOI:
10.1016/j.jve.2021.100032
No abstract available